We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Novel Device Contributes to Positive Phlebotomy Experience

By LabMedica International staff writers
Posted on 30 May 2018
Print article
Image: The BD Vacutainer UltraTouch push button blood collection set (Photo courtesy of Becton Dickinson).
Image: The BD Vacutainer UltraTouch push button blood collection set (Photo courtesy of Becton Dickinson).
Phlebotomy is a necessary procedure that may be a source of pain, stress and anxiety for some patients. While smaller gauge needles are known to lessen patient discomfort, they are often associated with increases in hemolysis or longer tube fill times.

A push button blood collection set has been engineered to minimize patient discomfort during blood collection. This device was evaluated for blood collection and allows clinicians to use a smaller gauge for easier access to small, difficult veins, without compromising tube fill time and sample quality.

Scientists from BD Life Sciences (Franklin Lakes, NJ, USA) conducted two studies with 214 subjects to compare pain and anxiety regarding future phlebotomy with three devices. Another study with 52 subjects assessed hemolysis in specimens collected with the two devices; bench testing evaluated tube-filling times with these devices.

The investigators evaluated the effect of a 5-bevel, 25-gauge blood collection set (BCS) with ultra-thin wall cannula (BD Vacutainer UltraTouch Push Button BCS (UltraTouch) on patient pain and anxiety compared with two 3-bevel, thin-wall, 23-gauge BCSs (BD Vacutainer Safety-Lok (Safety-Lok) and Greiner Bio-One Vacuette (Greiner, Kremsmünster, Austria). Hemolysis was evaluated visually, by Hemolysis Index and hemolysis-sensitive indicators potassium (K) and lactate dehydrogenase (LDH).

In a direct comparison with the BD Vacutainer UltraTouch blood collection set and traditional 23-gauge blood collection wingsets, the 25-gauge UltraTouch push button blood collection set demonstrated a statistically significant, 40% decrease in patient perceptions of insertion pain and 47% decrease in overall pain during blood collection, respectively. In addition, the study showed that the 25-gauge UltraTouch blood collection set did not increase hemolysis or increase tube filling times, in comparison to a traditional 23-gauge blood collection set. There was no significant difference in anxiety regarding future phlebotomy. No increase was observed in Hemolysis Index, K or LDH. Tube-filling times were comparable for each device.

The authors concluded that the 25-gauge UltraTouch provided less overall pain compared with the 23-gauge Vacuette, less pain upon needle insertion than the 23-gauge Safety-Lok, and no compromise in specimen quality or flow rate. The study was originally published in the July 2017 issue of The Journal of Applied Laboratory Medicine and was recently updated by Becton Dickinson.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.